For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231107:nRSG6874Sa&default-theme=true
RNS Number : 6874S Intl. Biotechnology Trust PLC 07 November 2023
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
(the "Company")
The Company was notified on 7 November 2023 that Caroline Gulliver,
Non-executive Director of the Company, purchased 2,500 Ordinary 25 pence
shares in the capital of the Company at a price of 573.1516 pence per Ordinary
share. As a result of this purchase, Caroline Gulliver's aggregate holding of
shares in the Company is 12,000 Ordinary shares, representing 0.03% of the
Company's issued share capital.
Notification of dealing form
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Caroline Gulliver
2 Reason for the notification
a) Position/status Non-executive Director of the Company
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name International Biotechnology Trust plc
b) LEI 213800N1QUJ744P76D11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares
Identification code GB0004559349
b) Nature of the transaction Share purchase
c) Price(s) and volume(s) Price(s) Volume(s)
573.1516p 2,500
d) Aggregated information Aggregated price Aggregated volume
N/A N/A
e) Date of the transaction 07 November 2023
f) Place of the transaction London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBLBDBXGGDGXR